This post was written by Naomi Buchanan. CAMBRIDGE, MA / ACCESSWIRE / November 25, 2024 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor ...

With the help of TBWA\Chiat\Day New York, pharma giant Moderna is demystifying mRNA science for the average consumer. This story is part of Convene. Challenge. Change., an editorial partnership ...

HSBC analyst Yifeng Liu upgraded Moderna (MRNA) to Buy from Hold with a price target of $58, down from $82. The recent share price weakness reflects worries over the company’s path back to ...

Major vaccine makers like Moderna, Inc. and Pfizer Inc. have seen declines in the period after Kennedy Jr.’s nomination. Pfizer’s and Moderna’s Covid-19 vaccines helped turn the tide of the ...

Kennedy Jr.'s nomination to lead HHS raises fears of reforms at the FDA and NIH. Investors are selling off Moderna and other vaccine stocks as speculation grows about reduced government support.

Don't Miss our Black Friday Offers: Mani Foroohar has given his Sell rating due to a combination of factors related to Moderna’s strategic decisions and financial adjustments. One of the key ...

Stocks linked to vaccine developers such as Moderna, Pfizer and Novavax tanked in the leadup to market close Thursday, tumbling after reports surfaced that President-elect Donald Trump would ...

Software giant Oracle Corp. is slashing its Massachusetts footprint with plans to vacate most of the buildings on its ...

The news, which came late in the day on Thursday, sent the shares of vaccine-makers sharply lower on Friday, with Moderna leading the losses, falling as much as 10%. Pfizer and Novavax both ...

US vaccine companies have already been struggling, thanks to lessened demand since the peak of the pandemic. Over the past year, Pfizer stock has dipped 11%, and Moderna stock has plunged 46%.